Takeda Pharmaceutical Company Limited | WebDisclosure

Basculer en Français

8609	Companies
141519	Keywords
77428	Articles
75628	Press releases

Headlines Articles Press releases Takeda Pharmaceutical Company Limited

Home
Companies
Takeda Pharmaceutical Company Limited

BRIEF

published on 01/30/2025 at 09:36, 2 months 11 days ago

Julie Kim to Take Over as CEO of Takeda in 2026

Takeda CEO Transition Julie Kim Christophe Weber Retirement Pharmaceutical Leadership Corporate Succession
BRIEF

published on 01/30/2025 at 09:36, 2 months 11 days ago

Julie Kim prendra la direction générale de Takeda en 2026

Succession D'entreprise Julie Kim Transition Au Poste De PDG De Takeda Départ À La Retraite De Christophe Weber Leadership Pharmaceutique
PRESS RELEASE

published on 01/30/2025 at 09:31, 2 months 11 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Julie Kim to succeed Christophe Weber as CEO of Takeda in June 2026. Board unanimously appoints her to lead after Weber's 12 successful years. Succession process concluded

Takeda Leadership CEO Succession Julie Kim Christophe Weber
BRIEF

published on 01/30/2025 at 07:35, 2 months 11 days ago

Takeda Pharmaceutical Revises FY2024 Financial Forecast

Revenue Growth Financial Performance Operating Profit FY2024 Forecast Takeda Pharmaceutical
BRIEF

published on 01/30/2025 at 07:35, 2 months 11 days ago

Takeda Pharmaceutical révise ses prévisions financières pour l'exercice 2024

Performance Financière Croissance Des Revenus Bénéfice D'exploitation Prévisions Pour L'exercice 2024 Takeda Pharmaceutique
PRESS RELEASE

published on 01/30/2025 at 07:30, 2 months 11 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical Company Limited announces revised financial forecast for FY2024, showing positive growth across revenue, profit, and earnings per share

Financial Forecast Takeda FY2024 Revised Forecast Core Financial Measures
BRIEF

published on 10/31/2024 at 07:05, 5 months 10 days ago

Takeda Revises FY2024 Financial Forecasts

Net Profit Growth Operating Profit Increase Takeda Financial Forecast FY2024 Revisions VYVANSE Impact
BRIEF

published on 10/31/2024 at 07:05, 5 months 10 days ago

Takeda révise ses prévisions financières pour l'exercice 2024

Croissance Du Bénéfice Net Prévisions Financières De Takeda Révisions Pour L'exercice 2024 L'impact De VYVANSE Augmentation Du Résultat D'exploitation
PRESS RELEASE

published on 10/31/2024 at 07:00, 5 months 10 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical revises FY2024 financial forecast, expecting growth in revenue and profit. Core metrics show positive trends. Details on the forecast and reasons for revision provided

Financials FY2024 Revised Forecast Takeda Pharmaceutical Core Metrics
BRIEF

published on 05/09/2024 at 08:05, 11 months 1 day ago

Takeda Launches Major Program to Boost Growth and Enhance Profit Margins

Takeda Pharmaceutical Growth Profit Margin Improvement Digital Investment Restructuring Costs

Accesswire

Published on 04/10/2025 at 19:00, 59 minutes ago

D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in Connection with its $4.0 Million Initial Public Offering
Published on 04/10/2025 at 15:15, 4 hours 44 minutes ago

ReelTime’s Reel Intelligence "RI" Outperforms AI While Requiring a Fraction of The Resources
Published on 04/10/2025 at 15:00, 4 hours 59 minutes ago

Route1 Signs Significant New Orders with Major Cities in the Southwestern United States and Announces Key Corporate Updates Including Its Acquisition Growth Strategy
Published on 04/10/2025 at 15:00, 4 hours 59 minutes ago

Inspire Veterinary Partners Announces Attendance at Upcoming Investor Events
Published on 04/10/2025 at 15:00, 4 hours 59 minutes ago

Xebra Brands Launches National RFP to Establish Cannabis Cultivation Partnerships Across Mexico

View all ACCESSWIRE

EQS Group

Published on 04/10/2025 at 19:00, 59 minutes ago

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Published on 04/10/2025 at 18:57, 1 hour 2 minutes ago

EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy
Published on 04/10/2025 at 18:28, 1 hour 31 minutes ago

Travis Perkins: Director/PDMR Shareholding
Published on 04/10/2025 at 18:19, 1 hour 40 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/10/2025 at 18:15, 1 hour 44 minutes ago

EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations

Les Echos

Published on 04/10/2025 at 18:04, 1 hour 55 minutes ago

Modalités de mise à disposition du Rapport sur la solvabilité et la situation financière 2024 du Groupe des Assurances du Crédit Mutuel
Published on 04/10/2025 at 18:03, 1 hour 56 minutes ago

Mise à disposition des états financiers 2024 du Groupe des Assurances du Crédit Mutuel
Published on 04/10/2025 at 18:00, 1 hour 59 minutes ago

SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2025
Published on 04/10/2025 at 18:00, 1 hour 59 minutes ago

i2S : Chiffre d'affaires 1er trimestre 2025
Published on 04/10/2025 at 17:45, 2 hours 14 minutes ago

EURAZEO INVESTIT DANS EKOSCAN INTEGRITY, ACTEUR DE REFERENCE DANS LES SOLUTIONS AVANCEES DE CONTROLE NON DESTRUCTIF POUR APPLICATIONS INDUSTRIELLES ET INFRASTRUCTURES CRITIQUES

View all LES ECHOS COMFI WIRE